-
Swarmer Promotes Garrett Kasper to CCO, Realigns Duties Among Executives
July 24, 2026 19:00 ET | Source: Swarmer AUSTIN, Texas, July 24, 2026 (GLOBE NEWSWIRE) — Swarmer, Inc (Nasdaq: SWMR) (“Swarmer” or the “Company”), a drone autonomy software company whose technology has supported more than 100,000 real-world combat missions in Ukraine since April 2024, today announced a promotion and realignment of duties among its executive…
-
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
July 23, 2026 21:08 ET | Source: Scribe Therapeutics Inc. ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) — Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, today announced the pricing of its upsized initial…
-
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the Paul-Ehrlich-Institute (PEI), regarding the underlying biology and proposed non-clinical development plan for its most-advanced development program based on its proprietary…
-
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share. The Company has now repurchased a…
-
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to support research and development (R&D) while strengthening collaboration and customer engagement. The…
-
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
July 13, 2026 20:35 ET | Source: Mesoblast Limited NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in the MSB-DR004 pivotal Phase 3 randomized controlled trial of rexlemestrocel-L…
-
Noble Capital Markets Initiates Equity Research Coverage on VivoPower
LONDON, UK / OSLO, NORWAY, July 13, 2026 (GLOBE NEWSWIRE) — VivoPower PLC (NASDAQ: VIVO) (“VivoPower” or the “Company”), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company with…
-
LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026
New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners July 12, 2026 11:18 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., July 12, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that new data…
-
Cellebrite Expands Exclusive SkySafe Partnership to Deliver Immediate Drone Detection and Airspace Intelligence for Digital Investigations at Scale
The partnership unifies what happens in the sky with what’s stored on the drone in a single investigative workflow TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 8, 2026 /PRNewswire/ — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced an expanded…
-
UK businesses drastically overestimate their AI progress
EXL’s 2026 UK Enterprise AI Study finds that while most companies think they’re ahead of the competition at AI, few actually see results at scale July 08, 2026 05:03 ET | Source: EXL 75% of companies believe they are ahead of their competitors on AI, but just 12% meet the criteria to qualify as an…
-
Iridium Completes Acquisition of Aireon
MCLEAN, Va., July 6, 2026 /PRNewswire/ — Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice, data, and positioning, navigation, and timing (PNT) satellite services, announced today that it has completed its acquisition of Aireon LLC, operator of the world’s only space-based Automatic Dependent Surveillance-Broadcast (ADS-B) air traffic surveillance system. “Iridium and Aireon are fully aligned…
-
Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)
Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
Alarum Technologies Announces Temporary Operational Pause of Certain Network Services
July 04, 2026 13:09 ET | Source: Alarum Technologies Ltd. Tel Aviv, Israel, July 04, 2026 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR) (“Alarum” or the “Company”) today announced the following update. Further to the Company’s announcements dated July 2 and July 3, 2026, the Company continues to investigate the recent incident…
-
POET Technologies Recaps Highlights of CEO’s Update on Commercial Activities and Provides Results of 2026 AGM
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported the voting results of its Annual General Meeting (the “AGM”), which was held virtually on Friday,…
-
Solidion Technology (Nasdaq: STI) Adopts SpaceX-Focused Treasury Strategy for Corporate Cash Reserves
Company intends to opportunistically acquire SpaceX shares as a long-term strategic treasury holding, reflecting alignment with the next era of aerospace, energy, and transportation infrastructure DALLAS, June 29, 2026 /PRNewswire/ — Solidion Technology, Inc. (Nasdaq: STI), an advanced battery materials and technology company, today announced that it intends to opportunistically acquire a position in SpaceX…
-
Shoals Technologies Group Secures ITC Victory Upholding American Intellectual Property
PORTLAND, Tenn., June 25, 2026 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals”) (Nasdaq: SHLS), a global leader in electrical infrastructure solutions for the energy transition market, announced a decisive victory in its patent infringement action against Voltage, LLC (“Voltage”) after the U.S. International Trade Commission affirmed the Administrative Law Judge’s (ALJ) ruling. The decision…
-
Noida International Airport selects Octave Attune EAM to build a unified asset intelligence foundation
The new deployment extends Octave’s mission to unleash intelligence at scale across India’s rapidly expanding aviation sector. JEWAR, India, June 24, 2026 /PRNewswire/ — Octave Intelligence plc (NASDAQ: OCTV), the global leader in software for the world’s most critical facilities and infrastructure, announced today that Noida International Airport (NIA) had adopted Octave Attune EAM (formerly…
-
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
– First patient dosed in a Phase 1 study evaluating ZM008, an anti-LLT1 mAb, in combination with LOQTORZI, a next-generation PD-1 inhibitor – June 23, 2026 14:00 ET | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. (“Zumutor”), an immuno-oncology biotech…
-
Dyne Therapeutics Appoints Barry Greene to Board of Directors
June 22, 2026 16:10 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., June 22, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment of Barry Greene to its Board of Directors. Mr. Greene brings more…
-
Eva Live Targets Cybersecurity Aggressively, Standing Up an Internal Task Force to Meet AI Industry Needs
Through its Eva Defense subsidiary, Eva Live is forming a dedicated internal cybersecurity task force to move hard and fast on acquisitions and partnerships LAS VEGAS, NV, June 22, 2026 (GLOBE NEWSWIRE) — Eva Live Inc. (NASDAQ: GOAI) (“Eva Live” or the “Company”), a technology company focused on artificial intelligence and digital innovation, today announced…
-
Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and Infrastructure
The company’s revolutionary, patented bipolar electrode-to-pack technology increases the battery energy and power densities; reducing weight, volume, and cost DALLAS, June 16, 2026 /PRNewswire/ — Solidion Technology, Inc. (Nasdaq: STI), an advanced battery technology solutions provider, today unveiled their patented bipolar electrode-to-pack (BEEP) battery technology, engineered to power electric vertical take-off and landing (eVTOL) aircraft,…
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
Solidion Technology’s 30+ Patents for Space-Based Artificial Intelligence Batteries Include the Highest-Performing Patented Lithium Anode Protection Technology
Game-Changing Anode Protection Platform Enabling All Ultra-High Energy Lithium Metal Batteries for Space and Commercial Applications DALLAS, June 5, 2026 /PRNewswire/ — Solidion Technology Inc. (“Solidion” or the “Company”) (NASDAQ: STI), an advanced battery technology solutions provider, today announced a patented breakthrough in lithium metal battery technology that removes the key stumbling blocks against full-scale…
-
Quantinuum Announces Closing of Upsized Initial Public Offering
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the…
-
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 4, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06,…
-
Solidion Technology Unveils Patented Extreme-Climate Battery Technology Targeting Low Earth Orbit-Based Artificial Intelligence Data Centers, Lunar Economy, and Space
Proprietary Gen-ECB Platform Engineered for Satellites, Starship Operations, Artemis Missions, and Orbital Infrastructure — Positioning Solidion at the Forefront of the Commercial Space Boom DALLAS, June 4, 2026 /PRNewswire/ — Solidion Technology Inc. (“Solidion” or the “Company”) (Nasdaq: STI), an advanced battery technology solutions provider, today announced a patented breakthrough in extreme-climate battery technology and…
-
Silvio Napoli Assumes Role as CEO of Lucid Following Completion of Leadership Transition
NEWARK, Calif., June 1, 2026 /PRNewswire/ — Lucid Group, Inc. (NASDAQ: LCID), maker of the world’s most advanced software-defined vehicles and technologies, today announced that Silvio Napoli has assumed the role of Chief Executive Officer (CEO), effective immediately. Napoli was previously announced as incoming CEO on April 14. “On behalf of the Board, we are pleased…
-
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development June 01, 2026 11:50 ET | Source: J-Star Holding Co., Ltd TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today provided additional details regarding the commitment…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
Acquisition supports Servier’s strategic ambition in rare neurology for patients with high unmet medical needs. Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. Transaction represents total value of up to $2.65 billion. SURESNES, France, June 1, 2026 /PRNewswire/ — Servier, an independent international pharmaceutical group governed by a foundation, today announced that…
-
TaskUs Honored at Times Business Awards for Driving the Future of AI-Powered Customer Experience
New Delhi, Delhi, India TaskUs (Nasdaq: TASK), a leading provider of outsourced digital services that power the companies shaping the future, has been honored at the prestigious Times Business Awards held in New Delhi. The company received the award for ‘Powering AI-Led CX Evolution and Innovation’, recognizing its contribution to advancing customer experience through technology-led…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.